These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18182036)

  • 1. Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation.
    Uitte de Willige S; De Visser MC; Vos HL; Houwing-Duistermaat JJ; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2008 Mar; 6(3):478-85. PubMed ID: 18182036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of factor V leiden, MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in Central Iran.
    Ehsani M; Imani A; Moravveji A
    Mol Biol Rep; 2018 Aug; 45(4):621-624. PubMed ID: 29855758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
    Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
    Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep venous thrombosis and thrombophilic mutations in western Iran: association with factor V Leiden.
    Rahimi Z; Mozafari H; Shahriari-Ahmadi A; Alimogaddam K; Ghavamzadeh A; Aznab M; Mansouri K; Rezaei M; Parsian A
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):385-8. PubMed ID: 20479641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden and the risk of venous thrombosis, myocardial infarction, and stroke: a case-control study in Venezuela.
    Pestana CI; Torres A; Blanco S; Rojas MJ; Méndez C; López JL; de Bosch NB; Porco A
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):537-42. PubMed ID: 19604111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss.
    Wüthrich RP; Cicvara-Muzar S; Booy C; Maly FE
    Transplantation; 2001 Aug; 72(3):549-50. PubMed ID: 11502996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
    Saemundsson Y; Sveinsdottir SV; Svantesson H; Svensson PJ
    J Thromb Thrombolysis; 2013 Oct; 36(3):324-31. PubMed ID: 23054468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.
    Hirmerova J; Seidlerova J; Subrt I
    QJM; 2014 Sep; 107(9):715-20. PubMed ID: 24633260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden is associated with increased sperm count.
    van Mens TE; Joensen UN; Bochdanovits Z; Takizawa A; Peter J; Jørgensen N; Szecsi PB; Meijers JCM; Weiler H; Rajpert-De Meyts E; Repping S; Middeldorp S
    Hum Reprod; 2017 Nov; 32(11):2332-2339. PubMed ID: 28927238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
    Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].
    Jastrzebska M; Bałszan-Kowalska I; Ciechanowicz A; Bińczak-Kuleta A; Falkowski A; Chełstowski K
    Pol Arch Med Wewn; 2003 Jun; 109(6):579-88. PubMed ID: 14567090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
    Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
    Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of venous thromboembolism and myocardial infarction with Factor V Leiden and Factor II gene mutations among Libyan patients.
    Msalati A; Bashein A; Ghrew M; Khalil I; Sedaa K; Ali A; Zaid A
    Libyan J Med; 2021 Dec; 16(1):1857525. PubMed ID: 33470184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients.
    Lüdemann P; Nabavi DG; Junker R; Wolff E; Papke K; Buchner H; Assmann G; Ringelstein EB
    Stroke; 1998 Dec; 29(12):2507-10. PubMed ID: 9836759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
    Morange PE; Aillaud MF; Nicaud V; Henry M; Juhan-Vague I
    Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.